Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 601 51 316.9 |
96 | EP file number | EAKZ | 09 01 0433.2 |
97 | EP publication number | EPN | 2116265 |
54 | Designation/title | TI | Niederviskose konzentrierte Proteinformulierungen |
51 | IPC main class | ICM (ICMV) | A61K 47/02 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 47/12 (2006.01), A61K 47/18 (2006.01), A61K 39/395 (2006.01) |
22 | DE application date | DAT | Oct 4, 2001 |
96 | EP application date | EAT | Oct 4, 2001 |
43 | Date of first publication | OT | Nov 11, 2009 |
| Date of publication of grant | PET | Dec 23, 2020 |
71/73 | Applicant/owner | INH | Genentech, Inc., South San Francisco, Calif., US; Novartis AG, 4056 Basel, CH |
72 | Inventor | IN | Liu, Jun, Pacifica CA 94044, US; Shire, Steven J., Belmont CA 94002, US |
| Address for service | | Genentech, Inc., SOUTH SAN FRANCISCO, CA 94080-4990, US |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 240107 P Oct 12, 2000
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 293834 P May 24, 2001
|
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000002116265 Searchable text:
EP000002116265 Original document:
EP000002116265B1 Searchable text:
EP000002116265B1 |
43 | Date of first publication | EVT | Nov 11, 2009 |
| Date of the first transfer into DPMAregister | EREGT | May 27, 2011 |
| Date of the (most recent) update in DPMAregister | REGT | Dec 1, 2021 (Show all update days)(Hide all update days)- Dec 1, 2021; Nov 11, 2021; Jan 8, 2021; Dec 3, 2020; Jan 10, 2019; Aug 20, 2015; Feb 13, 2013; Sep 1, 2011
- Historical data not available for this/these date(s)
- May 27, 2011
- Date of the first transfer into DPMAregister
|